These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 6248757)
1. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides. Davis CW; Daly JW Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757 [No Abstract] [Full Text] [Related]
2. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat. Levin RM; Weiss B Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349 [No Abstract] [Full Text] [Related]
3. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli. Iwasa Y Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507 [TBL] [Abstract][Full Text] [Related]
4. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system. Strada SJ; Martin MW; Thompson WJ Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518 [No Abstract] [Full Text] [Related]
10. Calcium-dependent 3':5'-cyclic nucleotide phosphodiesterase. Inhibition of basal activity at physiological levels of potassium ions. Davis CW; Daly JW J Biol Chem; 1978 Dec; 253(24):8683-6. PubMed ID: 214428 [TBL] [Abstract][Full Text] [Related]
11. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes. Perez de Gracia B; Rhoads AR; West WL Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634 [TBL] [Abstract][Full Text] [Related]
12. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain. Singh R; Shankar R Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810 [No Abstract] [Full Text] [Related]
13. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle. Pizarro M; Puente J; Sapag-Hagar M FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696 [No Abstract] [Full Text] [Related]
14. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration. Guan WR; Cheung WY Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844 [No Abstract] [Full Text] [Related]
15. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes. Hoskins B; Luong HB Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings]. Ilien B; Landry Y Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846 [No Abstract] [Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Epstein PM; Hachisu R Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124 [No Abstract] [Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms. Hait WN; Weiss B Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197 [No Abstract] [Full Text] [Related]
20. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate. King LE; Solomon SS; Hashimoto K Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705 [No Abstract] [Full Text] [Related] [Next] [New Search]